Works matching IS 00302414 AND DT 2014 AND VI 87 AND IP 1


Results: 9
    1

    Phase II Trial of Cetuximab plus Irinotecan for Oxaliplatin- and Irinotecan-Based Chemotherapy-Refractory Patients with Advanced and/or Metastatic Colorectal Cancer: Evaluation of Efficacy and Safety Based on KRAS Mutation Status (T-CORE0801)

    Published in:
    2014
    By:
    • Soeda, Hiroshi;
    • Shimodaira, Hideki;
    • Gamoh, Makio;
    • Ando, Hideaki;
    • Isobe, Hideki;
    • Suto, Takeshi;
    • Takahashi, Shin;
    • Kakudo, Yuichi;
    • Amagai, Kenji;
    • Mori, Takahiro;
    • Watanabe, Mika;
    • Yamaguchi, Takuhiro;
    • Kato, Shunsuke;
    • Ishioka, Chikashi
    Publication type:
    Journal Article
    2
    3

    Phase II Trial of Cetuximab plus Irinotecan for Oxaliplatin- and Irinotecan-Based Chemotherapy-Refractory Patients with Advanced and/or Metastatic Colorectal Cancer: Evaluation of Efficacy and Safety Based on KRAS Mutation Status (T-CORE0801).

    Published in:
    Oncology, 2014, v. 87, n. 1, p. 7, doi. 10.1159/000360989
    By:
    • Soeda, Hiroshi;
    • Shimodaira, Hideki;
    • Gamoh, Makio;
    • Ando, Hideaki;
    • Isobe, Hideki;
    • Suto, Takeshi;
    • Takahashi, Shin;
    • Kakudo, Yuichi;
    • Amagai, Kenji;
    • Mori, Takahiro;
    • Watanabe, Mika;
    • Yamaguchi, Takuhiro;
    • Kato, Shunsuke;
    • Ishioka, Chikashi
    Publication type:
    Article
    4

    Front & Back Matter.

    Published in:
    Oncology, 2014, v. 87, n. 1, p. X, doi. 10.1159/000365776
    Publication type:
    Article
    5
    6
    7
    8
    9